Scinovex
articleTop 1% cited

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Ophthalmology · 2012 · Vol. 119(12) · pp. 2537–2548
Jeffrey S. HeierDavid M. BrownVictor ChongJean‐François KorobelnikPeter K. KaiserQuan Dong NguyenBernd KirchhofAllen C. HoYuichiro OguraGeorge D. YancopoulosNeil StahlRobert VittiAlyson J. BerlinerYuhwen SooMajid AnderesiGeorg GroetzbachBernd SommerauerRupert SandbrinkChristian SimaderUrsula Schmidt‐Erfurth
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsAfliberceptRanibizumabMedicineMacular degenerationOphthalmologyChoroidal neovascularizationVisual acuityDosingClinical endpointDiabetic retinopathy

MeSH terms

RanibizumabAgedDouble-Blind MethodFemaleFluorescein AngiographyHumansMaleProspective StudiesRecombinant Fusion ProteinsVisual AcuityTreatment OutcomeSickness Impact ProfileRetreatmentAngiogenesis InhibitorsReceptors, Vascular Endothelial Growth Factor
Citations
2,431
FWCI
118.17
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration · Scinovex